LMWHs offer pharmacological advantages over unfractionated heparin, including better bioavailability, longer half-life, and reduced need for monitoring.
No takes yet. Share an insight, caveat, or question.
May support LMWH preference where monitoring is constrained; extends prior literature syntheses on anticoagulant selection.
Karen H. Gylys (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: